NEA Management Company as of Dec. 31, 2017
Portfolio Holdings for NEA Management Company
NEA Management Company holds 43 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 35.3 | $852M | 10M | 82.87 | |
| Glycomimetics (GLYC) | 6.0 | $144M | 8.6M | 16.79 | |
| Rhythm Pharmaceuticals (RYTM) | 5.9 | $143M | 4.9M | 29.06 | |
| Mersana Therapeutics (MRSN) | 5.5 | $134M | 8.1M | 16.43 | |
| Dermira | 4.0 | $98M | 3.5M | 27.81 | |
| Ardelyx (ARDX) | 3.9 | $93M | 14M | 6.60 | |
| Senseonics Hldgs (SENS) | 3.4 | $82M | 31M | 2.66 | |
| Epizyme | 3.4 | $81M | 6.5M | 12.55 | |
| Adaptimmune Therapeutics (ADAP) | 3.3 | $80M | 12M | 6.68 | |
| Crispr Therapeutics (CRSP) | 3.1 | $76M | 3.2M | 23.48 | |
| Achaogen | 2.3 | $56M | 5.2M | 10.74 | |
| AVEO Pharmaceuticals | 1.9 | $46M | 16M | 2.79 | |
| Immunomedics | 1.9 | $45M | 2.8M | 16.16 | |
| Obseva Sa | 1.9 | $45M | 4.6M | 9.76 | |
| Clementia | 1.7 | $41M | 2.1M | 18.98 | |
| Synlogic | 1.5 | $37M | 3.8M | 9.70 | |
| Cascadian Therapeutics | 1.4 | $34M | 9.1M | 3.70 | |
| Proteostasis Therapeutics In | 1.3 | $32M | 5.6M | 5.83 | |
| Strongbridge Bioph shs usd | 1.2 | $30M | 4.1M | 7.25 | |
| Ra Pharmaceuticals | 1.2 | $30M | 3.5M | 8.50 | |
| Tintri Inc. equity | 1.1 | $27M | 5.3M | 5.10 | |
| Arsanis | 1.1 | $26M | 2.0M | 12.76 | |
| Lexicon Pharmaceuticals (LXRX) | 1.0 | $24M | 2.4M | 9.88 | |
| Aurinia Pharmaceuticals (AUPH) | 0.9 | $22M | 4.8M | 4.53 | |
| Verona Pharma Plc ads (VRNA) | 0.6 | $15M | 1.2M | 11.87 | |
| Erytech Pharma Sa | 0.6 | $14M | 625k | 22.02 | |
| Endologix | 0.6 | $13M | 2.5M | 5.35 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $13M | 3.2M | 3.88 | |
| Regulus Therapeutics | 0.5 | $11M | 11M | 1.04 | |
| Nightstar Therapeutics | 0.4 | $9.4M | 714k | 13.12 | |
| Trillium Therapeutics, Inc. Cmn | 0.4 | $9.1M | 1.3M | 7.25 | |
| Tracon Pharmaceuticals | 0.4 | $9.2M | 2.8M | 3.35 | |
| Dasan Zhone Solutions | 0.4 | $8.9M | 956k | 9.26 | |
| Trevena | 0.2 | $6.1M | 3.8M | 1.60 | |
| Champions Oncology (CSBR) | 0.2 | $6.1M | 1.6M | 3.88 | |
| Affimed Therapeutics B V | 0.2 | $5.1M | 3.9M | 1.30 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $4.8M | 1.3M | 3.69 | |
| Mongodb Inc. Class A (MDB) | 0.2 | $4.5M | 150k | 29.68 | |
| ArQule | 0.2 | $4.2M | 2.5M | 1.65 | |
| Aquantia Corp | 0.1 | $2.7M | 240k | 11.33 | |
| Arca Biopharma | 0.1 | $2.0M | 1.5M | 1.35 | |
| Akari Therapeutics | 0.1 | $2.0M | 452k | 4.33 | |
| Orexigen Therapeutics | 0.0 | $479k | 371k | 1.29 |
